$CALM

Earnings call transcript: Cal-Maine Foods Q4 2026 miss hits shares as egg prices slump By Investing.com

Cal-Maine Foods reported a fiscal Q4 2026 diluted loss of $0.76 per share on revenue of $552.6 million, versus expectations for a profit of $0.11 on $657.1 million. The company cited severe egg market oversupply that drove conventional shell egg prices to historically low levels. Shares fell 4.31% to $83.49 premarket.

Original reporting
Published Jul 22, 2026, 3:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 4:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CALM
Bearish
high confidence
Mentioned
$CALM
Relevance
9/10
alphai data visualization · based on m.uk.investing.com
Decision brief

The 30-second read

$CALMBearishHigh
01

Why it matters

The report combines a large Q4 earnings miss with management guidance that early Q1 FY2027 egg prices are below normal, implying continued margin pressure until the market rebalances.

02

Market read

Traders can reassess CALM’s near-term earnings power based on the explicit Q1 FY2027 pricing commentary and the magnitude of the Q4 miss.

03

What to watch

Prepared foods and specialty eggs are cited as offsets, and the company remains virtually debt-free with $924.1M cash and temporary investments, which may reduce balance-sheet downside even if near-term earnings are pressured.

Relevance 9/10Novelty 8/10Timing: premarket reaction to Q4 FY2026 earnings miss and Q1 FY2027 pricing outlook

Background

Cal-Maine’s earnings are tightly linked to conventional shell egg pricing; the quarter’s results are framed as supply-driven oversupply rather than demand weakness.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

Cal-Maine reported Q4 FY2026 diluted loss of $0.76 and revenue of $552.6M, missing forecasts amid egg oversupply and price collapse.

Expected impact

Bearish near-term bias, with downside risk if conventional egg prices remain below mid-cycle levels into Q1 FY2027.

Evidence & confidence

The article provides concrete Q4 EPS and revenue misses plus management commentary that Q1 FY2027 pricing is still below normal, directly linking fundamentals to the stock’s premarket decline.

Market effects

Highlights how shell-egg commodity oversupply can rapidly compress margins for vertically integrated egg producers, reinforcing earnings sensitivity to pricing cycles.

Limited direct regional spillover, but US poultry/egg supply dynamics could influence related food supply chains.

Low global relevance; story is primarily US-centric commodity pricing and company-specific diversification execution.

Counterpoint

If management’s supply-tightening signals (slower breeder activity, chick cancellations, flock rotations) translate into sustained price recovery, the market may be over-discounting the duration of the downturn.

Key entities

  • Cal-Maine Foods

    Reported Q4 FY2026 diluted loss and weaker revenue due to historically low conventional egg prices from oversupply; outlined prepared foods and specialty growth plans.

Related articles

$CALMMedAI 8/10

Why Cal-Maine Foods Stock Just Cracked

Cal-Maine Foods (NASDAQ: CALM) shares fell about 3.7% by 9:45 a.m. ET after reporting Q4 results. Analysts expected EPS of $0.11 on $657M sales, but the company reported a loss of $0.76 per share on $552.6M sales. CEO Sherman Miller cited industry oversupply and low wholesale egg prices. 2026 revenue fell 32% and profit fell 73%.

$CALMMedAI 8/10

Cal-Maine Foods Stock Slips on Surprise Q4 Loss

Cal-Maine Foods (NASDAQ:CALM) shares fell after the company reported a fiscal Q4 loss of 76 cents per share, versus analysts expecting a profit of 11 cents. The firm cited historically low inflation-adjusted egg prices. Revenue dropped 49.9% year over year to $552.6 million. Stock was down 2.7% near $84.96.

$CALMMedAI 8/10

Cal-Maine Falls To Loss In Q4, Shares Down

Cal-Maine Foods (CALM) reported a Q4 2026 net loss of $35.88 million versus a $342.48 million profit a year earlier. Net loss per share was $0.76 versus EPS of $7.01. Revenue fell 49.9% to $552.58 million from $1.10 billion. Shares were down about 4.69% premarket to $83.16 on Nasdaq.

$SMCIMed

Stocks making the biggest moves premarket: Super Micro Computer, GE Vernova, Rocket Lab and more

Premarket movers included Super Micro Computer, up about 17% after preliminary Q4 results showed stronger profitability than expected, with revenue near low guidance. GE Vernova fell over 7% despite a revenue beat and raised full-year guidance. Rocket Lab rose about 4% on a $266 million U.S. Air Force contract. Pegasystems dropped over 14% after Q2 missed estimates; others moved on earnings or nuclear/AI news.

$CALMMed

Maine (NASDAQ:CALM) Misses Q2 CY2026 Sales Expectations

Cal-Maine Foods (NASDAQ: CALM) reported Q2 CY2026 revenue of $552.6 million, down 49.9% year over year, missing market expectations. The company posted a GAAP loss of $0.76 per share, better than analysts’ consensus. Management cited strategy to improve product mix and pricing. The stock fell 2.2% to $85.37 after results.